NEW YORK – A team of researchers in Singapore has developed a digital real-time PCR-based assay to measure telomere length.
Abnormal telomere length has been linked to a number of aging-related diseases such as diabetes, degenerative disease, and cardiovascular disease, as well as outcomes in various cancers. But the gold standard approach for measuring telomeres requires a large amount of starting DNA and is laborious, making it ill-suited for clinical use.